©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: DEA
Stocks Slide As Fears about DEA Dissent Boil Over
NEW YORK – An exchange-traded fund (ETF) that tracks some of the largest multistate operators (MSOs) fell nearly 17 percent during the first two...
Cannabis Caucus Co-Chair Will Not Support Federal Rescheduling
SACRAMENTO – Rep. Barbara Lee (D) is digging in on her all-or-nothing stance on federal cannabis reform, saying she believes the potential move to...
More States Seek Bans on Synthesized Cannabinoids
PIERRE, S.D. – South Dakota lawmakers are joining a growing chorus of state governments and federal agencies taking action against unregulated cannabinoids synthesized from...
DOJ Asks Federal Court to Dismiss Lawsuit Calling CSA ‘Unconstitutional’
BOSTON – The Department of Justice has asked a federal district court to dismiss a cannabis-industry lawsuit that seeks to bar federal enforcement action...
Congressional Report Confirms Changing Marijuana to a Schedule III Drug Would Maintain Federal Criminalization
WASHINGTON – A new report from the Congressional Research Service (CRS) confirms that marijuana would remain criminalized under federal law if moved to Schedule...
DEA Confirms Rescheduling Review
WASHINGTON – At long last, the notoriously tight-lipped Drug Enforcement Administration confirmed it is reviewing a recommendation that cannabis be moved from Schedule I...
A Post-280E Preview
While federal legalization is the ultimate goal for our industry, most cannabis professionals probably would list the elimination of Internal Revenue Code Section 280E...
Sinsemilla: A Potent Evolution in Cannabis
Sensimilla or “sinsemilla” is a seedless female cannabis plant bred to produce better buds, larger yields, and a more potent product.
Introduced to the legacy...
DEA Places 6 Synthetic Cannabinoids on Schedule I
WASHINGTON – Citing “imminent hazard to public safety,” the Drug Enforcement Administration temporarily placed six synthetic cannabinoids on Schedule I under the Controlled Substances...
Maridose Launches CRO Group for Cannabis-Based Drug Development
BRUNSWICK, Maine -- Maridose, a DEA-licensed manufacturer specializing in cannabis-based products, launched its Contract Research Organization (CRO) group. This newly formed group is dedicated to...